ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...

Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ICON plc ("ICON" or the ...

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year ...

ICON Public Limited (NASDAQ:ICLR – Get Free Report)’s share price reached a new 52-week low on Thursday after Truist Financial lowered their price target on the stock from $284.00 to $262.00. Truist ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

DUBLIN, January 29, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial ...